Skip to main content

LOGAN CAPITAL MANAGEMENT INC

Position in CRL — Charles River Laboratories International, Inc.

CIK 1121330 Newtown Square, PA

Position in CRL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,719,974
+$1,719,974 QoQ
Shares Held
7,584
Ownership
0.016%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#203
of 564 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 36% Shared 0% None 64%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Derivatives in CRL

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$1,308,239
PutShares
7,584

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

LOGAN CAPITAL MANAGEMENT INC holds $55,954,866 across 7 Diagnostics & Research names. CRL ranks #6 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 CRL
Charles River Laboratories International, Inc.
This page
7,584 $1,719,974

All Filings in CRL

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,719,974 7,584
2026-03-31 $1,308,239 7,584
2025-12-31 $2,189,292 10,975
2025-09-30 $2,036,638 13,017
2025-06-30 $1,682,229 11,087
2025-03-31 $1,742,118 11,574
2024-12-31 $4,071,537 22,056
2024-09-30 $4,674,097 23,730
2024-06-30 $4,958,952 24,005
2024-03-31 $6,599,799 24,358
2023-12-31 $5,001,514 21,157
2023-09-30 $4,616,699 23,557
2023-06-30 $4,357,430 20,725
2023-03-31 $4,684,847 23,213
2022-12-31 $4,864,398 22,324
2022-09-30 $4,419,340 22,456
2022-06-30 $4,405,642 20,590
2022-03-31 $6,172,371 21,736
2021-12-31 $8,032,949 21,320
2021-09-30 $8,586,837 20,808
2021-06-30 $7,923,316 21,419
2021-03-31 $5,718,345 19,730
2020-12-31 $4,562,942 18,262